InvestorsHub Logo
Followers 6
Posts 1257
Boards Moderated 0
Alias Born 06/14/2009

Re: None

Wednesday, 11/02/2022 9:11:28 AM

Wednesday, November 02, 2022 9:11:28 AM

Post# of 3683
Dan MUST have a deal in hand and is planning for the future ...According to the Cooperation Agreement from Feb. 2021, Healios can own up to 9.9% of Athersys shares. See the Comprehensive Framework Agreement from Aug. 2021:

https://www.sec.gov/Archives/edgar/data/1368148/000134100421000268/sc13d-a10.htm

The Framework Agreement also states that "Healios retains the right to appoint one nominee for election to the Issuer’s Board of Directors if Healios beneficially owns 5% or more of the Issuer’s outstanding shares of Common Stock. Dr. Kagimoto, Chairman and Chief Executive Officer of Healios, currently serves on the Issuer’s Board of Directors as the Healios designee." Healios ownership either went beneath the 5% threshold or will get there soon. According to the March 2018 agreement:

"during such time as Healios beneficially owns less than 15.0% but 5.0% or more of the Company’s outstanding common stock, the Board will nominate one of Healios’ nominees suitable to the Company to become a member of the Board at each annual election of directors."

https://www.sec.gov/Archives/edgar/data/1368148/000119312518085897/d551745d8k.htm

Healios owned 16,310,526 shares pre-RS which should be 652,421 post-RS.

The number of the outstanding shares is currently close to 13 million.

This is ALLLLLLLLL speculation IF and when Healios has the right to select a board member regarding Traub ... Which is NO GREAT LOSS ... GOOD LUCK LONGS